1772-Stimulated Protein Degradation for MitochondrialPaper Talk

1772-Stimulated Protein Degradation for Mitochondrial

25分钟 ·
播放数1
·
评论数0

The research discusses stimulated protein degradation as an innovative therapeutic strategy to tackle complex medical conditions characterized by pervasive protein dysregulation, such as neurodegenerative diseases. By utilizing small-molecule agonists to selectively dislodge inhibitory proteins from the stress-responsive E3 ubiquitin ligase CUL2 FEM1B, researchers can activate the enzyme without disrupting its normal substrate recognition. This targeted displacement successfully promotes mitochondrial function and enhances electron transport chain activity by degrading multiple physiological targets simultaneously. Consequently, this pharmacological approach restores neuronal survival in cellular models of conditions like Friedreich’s ataxia and COX deficiency syndrome. Ultimately, this methodology expands the clinical utility of induced protein degradation beyond traditional targeted applications to encompass complex pathologies previously lacking effective treatments.

References:

  • Chandrasekhar S, McMinimy R, Manford A G, et al. Stimulated protein degradation to promote mitochondrial function and neuronal survival[J]. Science, 2026, 394(6823): eaed2525.